# CGBIO signs $30M supply deal with India's Eris Lifesciences for Novosis

South Korean medical device company CGBIO signed a $30 million supply contract with India's Eris Lifesciences for its bone graft product Novosis. The deal covers the Indian market.

- Type: Contract
- Announced: 2019-09-09
- Where: India
- Value: $30.0M
- Status: announced
- Products: Novosis bone graft (rhBMP-2)
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [CGBIO](https://endata.com/companies/42255.md)
- [Eris Lifesciences](https://endata.com/companies/42256.md) (customer)

## Sources

- [cgbio.co.kr](https://www.cgbio.co.kr/17270), 2019-09-23: "노보시스는 글로벌 의료기기 공룡기업 메드트로닉이 독점하고 있는 골형성단백질 기반의 골재생 치료제 '인퓨즈'를 뛰어넘기 위해 13년간의 연구를 통해 개발된 제품"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.